Table 3.
Frequency-dosage measure of aspirin use and odds ratios for pancreatic cancer
| Aspirin use | Controls | Cases | OR* (95% CI) | P value |
|---|---|---|---|---|
| Tablets per month (mean, SD) | 13.5 ± 22.1 | 10.9 ± 18.2 | 0.990 (0.985-0.996) | 0.002 |
|
Frequency-dosage measure of
aspirin use (counts, %) |
n (%) | n (%) | ||
| Non-users | 270 (27.6) | 235 (33.7) | 1.00 | 0.022 |
| Light dose- infrequent use | 350 (35.8) | 242 (34.7) | 0.89 (0.69-1.02) | |
| Heavy dose- infrequent use | 123 (12.6) | 75 (10.8) | 0.74 (0.51-1.08) | |
| Light dose- frequent use | 186 (19.0) | 120 (17.2) | 0.65 (0.47-0.91) | |
| Heavy dose- frequent use | 49 (5.0) | 25 (3.6) | 0.52 (0.28-0.95) |
adjusted for age, sex, body mass index (continuous), smoking status (never, former, current), pack years of smoking and long standing diabetes mellitus (> 3 years)